Literature DB >> 35147816

Using Intervention Mapping to Develop a Novel Pain Self-Management Intervention for People with Cirrhosis.

Shari S Rogal1,2,3, Matthew J Chinman4,5, William DeMonte6, Sandra Gibson7,4, Stephanie Hoyt-Trapp7, Gloria J Klima4, Naudia L Jonassaint7,8, Jane M Liebschutz7, Kevin L Kraemer7, Jessica Merlin7.   

Abstract

BACKGROUND: Chronic pain is common among patients with cirrhosis and is challenging to treat. While promising, pain self-management (PSM) interventions have not been tailored to this population's needs. AIMS: To design a PSM intervention for patients with cirrhosis.
METHODS: Semi-structured interviews with 17 patients with cirrhosis, 12 hepatologists, and 6 administrators from two medical centers were conducted to inform a rigorous, structured intervention mapping (IM) process. Qualitative content analysis was guided by social cognitive theory (SCT) and the Consolidated Framework for Implementation Research (CFIR) and incorporated into intervention development. A planning group met regularly throughout the intervention, to reach consensus about how to use data and theory to develop the intervention through IM.
RESULTS: Participants described barriers to PSM behaviors, including the absence of simple, evidence-based interventions for pain for patients with cirrhosis, inadequate provider knowledge, time, and training, and lack of champions, funding, and communication. Patients described high motivation to treat pain using behavioral methods including meditation, prayer, and exercise. The intervention was designed to address barriers to PSM behaviors for patients with cirrhosis, using behavior change methods that address knowledge, self-efficacy, and outcome expectations. The LEAP (Liver Education About Pain) intervention is a 12-week, modular intervention delivered by phone via individual and group sessions with a health coach.
CONCLUSIONS: People with cirrhosis, hepatologists, and administrators informed this theory-driven, tailored PSM intervention, which was designed to be implementable in the real world.
© 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  Addiction; Chronic pain; Intervention mapping; Liver disease; Opioid

Year:  2022        PMID: 35147816     DOI: 10.1007/s10620-022-07380-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  54 in total

1.  Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey.

Authors:  R J Wong; B Liu; T Bhuket
Journal:  Aliment Pharmacol Ther       Date:  2017-09-15       Impact factor: 8.171

2.  Fibromyalgia symptoms and cirrhosis.

Authors:  Shari S Rogal; Klaus Bielefeldt; Ajay D Wasan; Eva Szigethy; Francis Lotrich; Andrea F DiMartini
Journal:  Dig Dis Sci       Date:  2014-11-30       Impact factor: 3.199

3.  Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis.

Authors:  Shari S Rogal; Klaus Bielefeldt; Ajay D Wasan; Francis E Lotrich; Susan Zickmund; Eva Szigethy; Andrea F DiMartini
Journal:  Clin Gastroenterol Hepatol       Date:  2014-11-05       Impact factor: 11.382

4.  Prevalence of chronic pain in a representative sample in the United States.

Authors:  Jochen Hardt; Clemma Jacobsen; Jack Goldberg; Ralf Nickel; Dedra Buchwald
Journal:  Pain Med       Date:  2008-03-11       Impact factor: 3.750

5.  Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.

Authors:  Lauren A Beste; Steven L Leipertz; Pamela K Green; Jason A Dominitz; David Ross; George N Ioannou
Journal:  Gastroenterology       Date:  2015-08-05       Impact factor: 22.682

6.  Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.

Authors:  Gary L Davis; Miriam J Alter; Hashem El-Serag; Thierry Poynard; Linda W Jennings
Journal:  Gastroenterology       Date:  2009-10-25       Impact factor: 22.682

7.  Healthcare utilization in chronic liver disease: the importance of pain and prescription opioid use.

Authors:  Shari S Rogal; Daniel Winger; Klaus Bielefeldt; Bruce L Rollman; Eva Szigethy
Journal:  Liver Int       Date:  2013-06-12       Impact factor: 5.828

8.  Pain and opioid use in chronic liver disease.

Authors:  Shari S Rogal; Daniel Winger; Klaus Bielefeldt; Eva Szigethy
Journal:  Dig Dis Sci       Date:  2013-03-20       Impact factor: 3.199

9.  Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework.

Authors:  Mandeep Sekhon; Martin Cartwright; Jill J Francis
Journal:  BMC Health Serv Res       Date:  2017-01-26       Impact factor: 2.655

10.  The assessment and management of pain in cirrhosis.

Authors:  Matthew Klinge; Tami Coppler; Jane M Liebschutz; Mohannad Dugum; Ajay Wassan; Andrea DiMartini; Shari Rogal
Journal:  Curr Hepatol Rep       Date:  2018-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.